CITRAPHOS TAB

Description

Composition:

• Each tablet contains Ferric Citrate, providing 210 mg of elemental iron.

Manufacturer:

• La Renon Healthcare Pvt Ltd

Therapeutic Uses:

• Iron Deficiency Anemia: Ferric Citrate supplies bioavailable iron essential for hemoglobin production, aiding in the treatment of anemia.

• Hyperphosphatemia: Acts as a phosphate binder by binding dietary phosphorus in the gastrointestinal tract, thereby reducing its absorption.

Mechanism of Action:

• Ferric Citrate binds to dietary phosphate in the digestive system, forming insoluble complexes that are excreted, thus lowering serum phosphate levels.

• Simultaneously, it provides elemental iron, which is absorbed and utilized in hemoglobin synthesis.

Dosage and Administration:

• Dosage should be individualized based on the patient’s serum phosphate levels and iron parameters.

• Typically taken orally with meals to enhance phosphate binding.

• Patients should follow their healthcare provider’s instructions regarding dosage and duration.

Safety Information:

• Store at room temperature, away from moisture and direct sunlight.

• Keep out of reach of children.

• Use with caution in patients with a history of iron overload disorders.

• Consult a healthcare provider before use during pregnancy or breastfeeding.

Potential Side Effects:

• Gastrointestinal disturbances such as nausea, vomiting, diarrhea, or constipation.

• Dark-colored stools due to iron content.

• Elevated serum ferritin and transferrin saturation levels.

• Allergic reactions in rare cases.

Precautions:

• Regular monitoring of serum phosphate, iron parameters, and complete blood count is recommended during therapy.

• Adjust dosage based on laboratory results and clinical response.